AgriMetis announces additional issued patents protecting its SpinoMetis™ insecticides

AgriMetis, LLC announces that two additional patents covering novel chemicals and methods of making its spinosyn-derived insecticide, SpinoMetis™ have been issued as U.S. Patent Nos. 10,711,026 and 10,717,756 by the U.S. Patent and Trademark Office. Additional U.S. and international applications filed by the company are still pending.   

SpinoMetis compounds are novel semi-synthetic active ingredients from the highly sought-after spinosyn class of chemistry and mode of action (IRAC group 5). AgriMetis starts with natural products from the fermentation of a microbial organism, which are then optimized to produce the SpinoMetis active ingredient. Field trials conducted during 2019 in North and South America against a variety of important pests have shown superior control with the SpinoMetis lead compound compared to commercial standards. AgriMetis has developed several microbial strains to produce natural spinosyn compounds with high yields, including compounds that make the precursors to the SpinoMetis active ingredients.

“These issued patents are further demonstration of the progress that we are making toward delivering new and improved products within this class of chemicals,” stated Dr. Brian Green, Vice President of Research and Development of AgriMetis.